Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 190

1.

Immune Responses to Gametocyte Antigens in a Malaria Endemic Population-The African falciparum Context: A Systematic Review and Meta-Analysis.

Muthui MK, Kamau A, Bousema T, Blagborough AM, Bejon P, Kapulu MC.

Front Immunol. 2019 Oct 22;10:2480. doi: 10.3389/fimmu.2019.02480. eCollection 2019.

2.

Prevalence of Plasmodium falciparum Pfcrt and Pfmdr1 alleles in settings with different levels of Plasmodium vivax co-endemicity in Ethiopia.

Hailemeskel E, Menberu T, Shumie G, Behaksra S, Chali W, Keffale M, Belachew M, Shitaye G, Mohammed H, Abebe D, Ashine T, Drakeley C, Mamo H, Petros B, Bousema T, Tadesse FG, Gadisa E.

Int J Parasitol Drugs Drug Resist. 2019 Dec;11:8-12. doi: 10.1016/j.ijpddr.2019.09.002. Epub 2019 Sep 9.

3.

Investigating the impact of enhanced community case management and monthly screening and treatment on the transmissibility of malaria infections in Burkina Faso: study protocol for a cluster-randomised trial.

Collins KA, Ouedraogo A, Guelbeogo WM, Awandu SS, Stone W, Soulama I, Ouattara MS, Nombre A, Diarra A, Bradley J, Selvaraj P, Gerardin J, Drakeley C, Bousema T, Tiono A.

BMJ Open. 2019 Sep 13;9(9):e030598. doi: 10.1136/bmjopen-2019-030598.

4.

Malaria Hotspots: Is There Epidemiological Evidence for Fine-Scale Spatial Targeting of Interventions?

Stresman G, Bousema T, Cook J.

Trends Parasitol. 2019 Oct;35(10):822-834. doi: 10.1016/j.pt.2019.07.013. Epub 2019 Aug 29. Review.

5.

Field performance of the malaria highly sensitive rapid diagnostic test in a setting of varying malaria transmission.

Mwesigwa J, Slater H, Bradley J, Saidy B, Ceesay F, Whittaker C, Kandeh B, Nkwakamna D, Drakeley C, Van Geertruyden JP, Bousema T, Achan J, D'Alessandro U.

Malar J. 2019 Aug 27;18(1):288. doi: 10.1186/s12936-019-2929-1.

6.

Is that a real oocyst? Insectary establishment and identification of Plasmodium falciparum oocysts in midguts of Anopheles mosquitoes fed on infected human blood in Tororo, Uganda.

Musiime AK, Okoth J, Conrad M, Ayo D, Onyige I, Rek J, Nankabirwa JI, Arinaitwe E, Kamya MR, Dorsey G, van Gemert GJ, Staedke SG, Drakeley C, Bousema T, Andolina C.

Malar J. 2019 Aug 27;18(1):287. doi: 10.1186/s12936-019-2922-8.

7.

Molecular and immunofluorescence-based quantification of male and female gametocytes in low-density P. falciparum infections and their relevance for transmission.

Gruenberg M, Hofmann NE, Nate E, Karl S, Robinson LJ, Lanke K, Smith TA, Bousema T, Felger I.

J Infect Dis. 2019 Aug 22. pii: jiz420. doi: 10.1093/infdis/jiz420. [Epub ahead of print]

PMID:
31437280
8.

Serologic markers of previous malaria exposure and functional antibodies inhibiting parasite growth are associated with parasite kinetics following a Plasmodium falciparum controlled human infection.

Achan J, Reuling I, Yap XZ, Dabira E, Ahmad A, Cox M, Nwakanma D, Tetteh K, Wu L, Bastiaens GJH, Abebe Y, Manoj A, Kaur H, Miura K, Long C, Billingsley PF, Sim BKL, Hoffman SL, Drakeley C, Bousema T, D'Alessandro U.

Clin Infect Dis. 2019 Aug 12. pii: ciz740. doi: 10.1093/cid/ciz740. [Epub ahead of print]

PMID:
31402382
9.

CYP2D6 Polymorphisms and the Safety and Gametocytocidal Activity of Single-Dose Primaquine for Plasmodium falciparum.

Pett H, Bradley J, Okebe J, Dicko A, Tiono AB, Gonçalves BP, Stone W, Chen I, Lanke K, Neuvonen M, Mustaniemi AL, Eziefula AC, Gosling R, D'Alessandro U, Drakeley C, Niemi M, Bousema T.

Antimicrob Agents Chemother. 2019 Sep 23;63(10). pii: e00538-19. doi: 10.1128/AAC.00538-19. Print 2019 Oct.

10.

Author Correction: The temporal dynamics and infectiousness of subpatent Plasmodium falciparum infections in relation to parasite density.

Slater HC, Ross A, Felger I, Hofmann NE, Robinson L, Cook J, Gonçalves BP, Björkman A, Ouedraogo AL, Morris U, Msellem M, Koepfli C, Mueller I, Tadesse F, Gadisa E, Das S, Domingo G, Kapulu M, Midega J, Owusu-Agyei S, Nabet C, Piarroux R, Doumbo O, Doumbo SN, Koram K, Lucchi N, Udhayakumar V, Mosha J, Tiono A, Chandramohan D, Gosling R, Mwingira F, Sauerwein R, Paul R, Riley EM, White NJ, Nosten F, Imwong M, Bousema T, Drakeley C, Okell LC.

Nat Commun. 2019 Jun 11;10(1):2644. doi: 10.1038/s41467-019-10790-0.

11.

Naturally acquired immunity against immature Plasmodium falciparum gametocytes.

Dantzler KW, Ma S, Ngotho P, Stone WJR, Tao D, Rijpma S, De Niz M, Nilsson Bark SK, Jore MM, Raaijmakers TK, Early AM, Ubaida-Mohien C, Lemgruber L, Campo JJ, Teng AA, Le TQ, Walker CL, Hermand P, Deterre P, Davies DH, Felgner P, Morlais I, Wirth DF, Neafsey DE, Dinglasan RR, Laufer M, Huttenhower C, Seydel K, Taylor T, Bousema T, Marti M.

Sci Transl Med. 2019 Jun 5;11(495). pii: eaav3963. doi: 10.1126/scitranslmed.aav3963.

12.

The XN-30 hematology analyzer for rapid sensitive detection of malaria: a diagnostic accuracy study.

Post A, Kaboré B, Reuling IJ, Bognini J, van der Heijden W, Diallo S, Lompo P, Kam B, Herssens N, Lanke K, Bousema T, Sauerwein RW, Tinto H, Jacobs J, de Mast Q, van der Ven AJ.

BMC Med. 2019 May 31;17(1):103. doi: 10.1186/s12916-019-1334-5.

13.

Functional antibodies against Plasmodium falciparum sporozoites are associated with a longer time to qPCR-detected infection among schoolchildren in Burkina Faso.

Barry A, Behet MC, Nébié I, Lanke K, Grignard L, Ouedraogo A, Soulama I, Drakeley C, Sauerwein R, Bolscher JM, Dechering KJ, Bousema T, Tiono AB, Gonçalves BP.

Version 2. Wellcome Open Res. 2019 May 1 [revised 2019 Jan 1];3:159. doi: 10.12688/wellcomeopenres.14932.2. eCollection 2018.

14.

Plasmodium malariae and Plasmodium ovale infections and their association with common red blood cell polymorphisms in a highly endemic area of Uganda.

Subissi L, Kanoi BN, Balikagala B, Egwang TG, Oguike M, Verra F, Proietti C, Bousema T, Drakeley CJ, Sepúlveda N.

Trans R Soc Trop Med Hyg. 2019 Jul 1;113(7):370-378. doi: 10.1093/trstmh/trz015.

PMID:
30953444
15.

Serological evidence for a decline in malaria transmission following major scale-up of control efforts in a setting selected for Plasmodium vivax and Plasmodium falciparum malaria elimination in Babile district, Oromia, Ethiopia.

Keffale M, Shumie G, Behaksra SW, Chali W, Hoogen LLVD, Hailemeskel E, Mekonnen D, Chanyalew M, Damte D, Fanta T, Ashine T, Chali S, Tetteh KKA, Birhanu DD, Balcha TT, Aseffa A, Drakeley C, Tessema TS, Adamu H, Bousema T, Gadisa E, Tadesse FG.

Trans R Soc Trop Med Hyg. 2019 Jun 1;113(6):305-311. doi: 10.1093/trstmh/trz005.

16.

The temporal dynamics and infectiousness of subpatent Plasmodium falciparum infections in relation to parasite density.

Slater HC, Ross A, Felger I, Hofmann NE, Robinson L, Cook J, Gonçalves BP, Björkman A, Ouedraogo AL, Morris U, Msellem M, Koepfli C, Mueller I, Tadesse F, Gadisa E, Das S, Domingo G, Kapulu M, Midega J, Owusu-Agyei S, Nabet C, Piarroux R, Doumbo O, Doumbo SN, Koram K, Lucchi N, Udhayakumar V, Mosha J, Tiono A, Chandramohan D, Gosling R, Mwingira F, Sauerwein R, Paul R, Riley EM, White NJ, Nosten F, Imwong M, Bousema T, Drakeley C, Okell LC.

Nat Commun. 2019 Mar 29;10(1):1433. doi: 10.1038/s41467-019-09441-1. Erratum in: Nat Commun. 2019 Jun 11;10(1):2644.

17.

Molecular quantification of Plasmodium parasite density from the blood retained in used RDTs.

Robinson A, Busula AO, Muwanguzi JK, Powers SJ, Masiga DK, Bousema T, Takken W, de Boer JG, Logan JG, Beshir KB, Sutherland CJ.

Sci Rep. 2019 Mar 25;9(1):5107. doi: 10.1038/s41598-019-41438-0.

18.

Ultralow-density Plasmodium falciparum Infections in African Settings.

Awandu SS, Raman J, Bousema T, Birkholtz LM.

Clin Infect Dis. 2019 Sep 27;69(8):1463-1464. doi: 10.1093/cid/ciz147. No abstract available.

19.

Transmission-blocking Effects of Primaquine and Methylene Blue Suggest Plasmodium falciparum Gametocyte Sterilization Rather Than Effects on Sex Ratio.

Bradley J, Soumaré HM, Mahamar A, Diawara H, Roh M, Delves M, Drakeley C, Churcher TS, Dicko A, Gosling R, Bousema T.

Clin Infect Dis. 2019 Sep 27;69(8):1436-1439. doi: 10.1093/cid/ciz134.

20.

Antibody Responses to Antigenic Targets of Recent Exposure Are Associated With Low-Density Parasitemia in Controlled Human Plasmodium falciparum Infections.

van den Hoogen LL, Walk J, Oulton T, Reuling IJ, Reiling L, Beeson JG, Coppel RL, Singh SK, Draper SJ, Bousema T, Drakeley C, Sauerwein R, Tetteh KKA.

Front Microbiol. 2019 Jan 16;9:3300. doi: 10.3389/fmicb.2018.03300. eCollection 2018.

21.

Bead-based assays to simultaneously detect multiple human inherited blood disorders associated with malaria.

Grignard L, Mair C, Curry J, Mahey L, Bastiaens GJH, Tiono AB, Okebe J, Coulibaly SA, Gonçalves BP, Affara M, Ouédraogo A, Bougouma EC, Sanou GS, Nébié I, Lanke KHW, Sirima SB, d'Alessandro U, Clark TG, Campino S, Bousema T, Drakeley C.

Malar J. 2019 Jan 21;18(1):14. doi: 10.1186/s12936-019-2648-7.

22.

Plasmodium falciparum Gametocyte Enrichment in Peripheral Blood Samples by Magnetic Fractionation: Gametocyte Yields and Possibilities to Reuse Columns.

Graumans W, Andolina C, Awandu SS, Grignard L, Lanke K, Bousema T.

Am J Trop Med Hyg. 2019 Mar;100(3):572-577. doi: 10.4269/ajtmh.18-0773.

23.

Gametocyte Sex Ratio: The Key to Understanding Plasmodium falciparum Transmission?

Tadesse FG, Meerstein-Kessel L, Gonçalves BP, Drakeley C, Ranford-Cartwright L, Bousema T.

Trends Parasitol. 2019 Mar;35(3):226-238. doi: 10.1016/j.pt.2018.12.001. Epub 2018 Dec 26. Review.

24.

Human Direct Skin Feeding Versus Membrane Feeding to Assess the Mosquitocidal Efficacy of High-Dose Ivermectin (IVERMAL Trial).

Smit MR, Ochomo EO, Aljayyoussi G, Kwambai TK, Abong'o BO, Bousema T, Waterhouse D, Bayoh NM, Gimnig JE, Samuels AM, Desai MR, Phillips-Howard PA, Kariuki SK, Wang D, Ward SA, Ter Kuile FO.

Clin Infect Dis. 2019 Sep 13;69(7):1112-1119. doi: 10.1093/cid/ciy1063.

25.

Two-Faced Immunity? The Evidence for Antibody Enhancement of Malaria Transmission.

Stone W, Bousema T, Sauerwein R, Drakeley C.

Trends Parasitol. 2019 Feb;35(2):140-153. doi: 10.1016/j.pt.2018.11.003. Epub 2018 Dec 17. Review.

PMID:
30573175
26.

A multiplex assay for the sensitive detection and quantification of male and female Plasmodium falciparum gametocytes.

Meerstein-Kessel L, Andolina C, Carrio E, Mahamar A, Sawa P, Diawara H, van de Vegte-Bolmer M, Stone W, Collins KA, Schneider P, Dicko A, Drakeley C, Felger I, Voss T, Lanke K, Bousema T.

Malar J. 2018 Nov 29;17(1):441. doi: 10.1186/s12936-018-2584-y.

27.

Mass Drug Administration With Dihydroartemisinin-piperaquine and Malaria Transmission Dynamics in The Gambia: A Prospective Cohort Study.

Mwesigwa J, Achan J, Affara M, Wathuo M, Worwui A, Mohammed NI, Kanuteh F, Prom A, Dierickx S, di Tanna GL, Nwakanma D, Bousema T, Drakeley C, Van Geertruyden JP, D'Alessandro U.

Clin Infect Dis. 2019 Jul 2;69(2):278-286. doi: 10.1093/cid/ciy870.

28.

Liver Injury in Uncomplicated Malaria is an Overlooked Phenomenon: An Observational Study.

Reuling IJ, de Jong GM, Yap XZ, Asghar M, Walk J, van de Schans LA, Koelewijn R, Färnert A, de Mast Q, van der Ven AJ, Bousema T, van Hellemond JJ, van Genderen PJJ, Sauerwein RW.

EBioMedicine. 2018 Oct;36:131-139. doi: 10.1016/j.ebiom.2018.09.018. Epub 2018 Sep 19. No abstract available.

29.

Do hotspots fuel malaria transmission: a village-scale spatio-temporal analysis of a 2-year cohort study in The Gambia.

Stresman GH, Mwesigwa J, Achan J, Giorgi E, Worwui A, Jawara M, Di Tanna GL, Bousema T, Van Geertruyden JP, Drakeley C, D'Alessandro U.

BMC Med. 2018 Sep 14;16(1):160. doi: 10.1186/s12916-018-1141-4.

30.

Pharmacokinetics-Pharmacodynamics of High-Dose Ivermectin with Dihydroartemisinin-Piperaquine on Mosquitocidal Activity and QT-Prolongation (IVERMAL).

Smit MR, Ochomo EO, Waterhouse D, Kwambai TK, Abong'o BO, Bousema T, Bayoh NM, Gimnig JE, Samuels AM, Desai MR, Phillips-Howard PA, Kariuki SK, Wang D, Ter Kuile FO, Ward SA, Aljayyoussi G.

Clin Pharmacol Ther. 2019 Feb;105(2):388-401. doi: 10.1002/cpt.1219. Epub 2018 Oct 9.

31.

Low and heterogeneous prevalence of glucose-6-phosphate dehydrogenase deficiency in different settings in Ethiopia using phenotyping and genotyping approaches.

Shitaye G, Gadisa E, Grignard L, Shumie G, Chali W, Menberu T, Belachew M, Tegegn G, Challi S, Curry J, Mahey L, Hailu T, Mamo H, Menon M, Balcha T, Aseffa A, Drakeley C, Bousema T, Tadesse FG.

Malar J. 2018 Aug 2;17(1):281. doi: 10.1186/s12936-018-2437-8.

32.

Haemolysis and haem oxygenase-1 induction during persistent "asymptomatic" malaria infection in Burkinabé children.

Mooney JP, Barry A, Gonçalves BP, Tiono AB, Awandu SS, Grignard L, Drakeley CJ, Bottomley C, Bousema T, Riley EM.

Malar J. 2018 Jul 6;17(1):253. doi: 10.1186/s12936-018-2402-6.

33.

Assessing Plasmodium falciparum transmission in mosquito-feeding assays using quantitative PCR.

Wang CYT, McCarthy JS, Stone WJ, Bousema T, Collins KA, Bialasiewicz S.

Malar J. 2018 Jul 5;17(1):249. doi: 10.1186/s12936-018-2382-6.

34.

Repurposing isoxazoline veterinary drugs for control of vector-borne human diseases.

Miglianico M, Eldering M, Slater H, Ferguson N, Ambrose P, Lees RS, Koolen KMJ, Pruzinova K, Jancarova M, Volf P, Koenraadt CJM, Duerr HP, Trevitt G, Yang B, Chatterjee AK, Wisler J, Sturm A, Bousema T, Sauerwein RW, Schultz PG, Tremblay MS, Dechering KJ.

Proc Natl Acad Sci U S A. 2018 Jul 17;115(29):E6920-E6926. doi: 10.1073/pnas.1801338115. Epub 2018 Jul 2.

35.

Plasmodium falciparum gametocyte dynamics after pyronaridine-artesunate or artemether-lumefantrine treatment.

Roth JM, Sawa P, Omweri G, Osoti V, Makio N, Bradley J, Bousema T, Schallig HDFH, Mens PF.

Malar J. 2018 Jun 4;17(1):223. doi: 10.1186/s12936-018-2373-7.

36.

Predicting the likelihood and intensity of mosquito infection from sex specific Plasmodium falciparum gametocyte density.

Bradley J, Stone W, Da DF, Morlais I, Dicko A, Cohuet A, Guelbeogo WM, Mahamar A, Nsango S, Soumaré HM, Diawara H, Lanke K, Graumans W, Siebelink-Stoter R, van de Vegte-Bolmer M, Chen I, Tiono A, Gonçalves BP, Gosling R, Sauerwein RW, Drakeley C, Churcher TS, Bousema T.

Elife. 2018 May 31;7. pii: e34463. doi: 10.7554/eLife.34463.

37.

Modeling the impact of Plasmodium falciparum sexual stage immunity on the composition and dynamics of the human infectious reservoir for malaria in natural settings.

Ouédraogo AL, Eckhoff PA, Luty AJF, Roeffen W, Sauerwein RW, Bousema T, Wenger EA.

PLoS Pathog. 2018 May 9;14(5):e1007034. doi: 10.1371/journal.ppat.1007034. eCollection 2018 May.

38.

Transmission of molecularly undetectable circulating parasite clones leads to high infection complexity in mosquitoes post feeding.

Grignard L, Gonçalves BP, Early AM, Daniels RF, Tiono AB, Guelbéogo WM, Ouédraogo A, van Veen EM, Lanke K, Diarra A, Nebie I, Sirima SB, Targett GA, Volkman SK, Neafsey DE, Wirth DF, Bousema T, Drakeley C.

Int J Parasitol. 2018 Jul;48(8):671-677. doi: 10.1016/j.ijpara.2018.02.005. Epub 2018 May 5.

39.

Plasmodium-associated changes in human odor attract mosquitoes.

Robinson A, Busula AO, Voets MA, Beshir KB, Caulfield JC, Powers SJ, Verhulst NO, Winskill P, Muwanguzi J, Birkett MA, Smallegange RC, Masiga DK, Mukabana WR, Sauerwein RW, Sutherland CJ, Bousema T, Pickett JA, Takken W, Logan JG, de Boer JG.

Proc Natl Acad Sci U S A. 2018 May 1;115(18):E4209-E4218. doi: 10.1073/pnas.1721610115. Epub 2018 Apr 16.

40.

Publisher Correction: Unravelling the immune signature of Plasmodium falciparum transmission-reducing immunity.

Stone WJR, Campo JJ, Ouédraogo AL, Meerstein-Kessel L, Morlais I, Da D, Cohuet A, Nsango S, Sutherland CJ, van de Vegte-Bolmer M, Siebelink-Stoter R, van Gemert GJ, Graumans W, Lanke K, Shandling AD, Pablo JV, Teng AA, Jones S, de Jong RM, Fabra-García A, Bradley J, Roeffen W, Lasonder E, Gremo G, Schwarzer E, Janse CJ, Singh SK, Theisen M, Felgner P, Marti M, Drakeley C, Sauerwein R, Bousema T, Jore MM.

Nat Commun. 2018 Apr 11;9(1):1498. doi: 10.1038/s41467-018-03769-w.

41.

Safety and mosquitocidal efficacy of high-dose ivermectin when co-administered with dihydroartemisinin-piperaquine in Kenyan adults with uncomplicated malaria (IVERMAL): a randomised, double-blind, placebo-controlled trial.

Smit MR, Ochomo EO, Aljayyoussi G, Kwambai TK, Abong'o BO, Chen T, Bousema T, Slater HC, Waterhouse D, Bayoh NM, Gimnig JE, Samuels AM, Desai MR, Phillips-Howard PA, Kariuki SK, Wang D, Ward SA, Ter Kuile FO.

Lancet Infect Dis. 2018 Jun;18(6):615-626. doi: 10.1016/S1473-3099(18)30163-4. Epub 2018 Mar 27.

42.

Understanding human genetic factors influencing primaquine safety and efficacy to guide primaquine roll-out in a pre-elimination setting in southern Africa.

Awandu SS, Raman J, Makhanthisa TI, Kruger P, Frean J, Bousema T, Niemand J, Birkholtz LM.

Malar J. 2018 Mar 20;17(1):120. doi: 10.1186/s12936-018-2271-z.

43.

A randomized feasibility trial comparing four antimalarial drug regimens to induce Plasmodium falciparum gametocytemia in the controlled human malaria infection model.

Reuling IJ, van de Schans LA, Coffeng LE, Lanke K, Meerstein-Kessel L, Graumans W, van Gemert GJ, Teelen K, Siebelink-Stoter R, van de Vegte-Bolmer M, de Mast Q, van der Ven AJ, Ivinson K, Hermsen CC, de Vlas S, Bradley J, Collins KA, Ockenhouse CF, McCarthy J, Sauerwein RW, Bousema T.

Elife. 2018 Feb 27;7. pii: e31549. doi: 10.7554/eLife.31549.

44.

Unravelling the immune signature of Plasmodium falciparum transmission-reducing immunity.

Stone WJR, Campo JJ, Ouédraogo AL, Meerstein-Kessel L, Morlais I, Da D, Cohuet A, Nsango S, Sutherland CJ, van de Vegte-Bolmer M, Siebelink-Stoter R, van Gemert GJ, Graumans W, Lanke K, Shandling AD, Pablo JV, Teng AA, Jones S, de Jong RM, Fabra-García A, Bradley J, Roeffen W, Lasonder E, Gremo G, Schwarzer E, Janse CJ, Singh SK, Theisen M, Felgner P, Marti M, Drakeley C, Sauerwein R, Bousema T, Jore MM.

Nat Commun. 2018 Feb 8;9(1):558. doi: 10.1038/s41467-017-02646-2. Erratum in: Nat Commun. 2018 Apr 11;9(1):1498.

45.

Efficacy and safety of primaquine and methylene blue for prevention of Plasmodium falciparum transmission in Mali: a phase 2, single-blind, randomised controlled trial.

Dicko A, Roh ME, Diawara H, Mahamar A, Soumare HM, Lanke K, Bradley J, Sanogo K, Kone DT, Diarra K, Keita S, Issiaka D, Traore SF, McCulloch C, Stone WJR, Hwang J, Müller O, Brown JM, Srinivasan V, Drakeley C, Gosling R, Chen I, Bousema T.

Lancet Infect Dis. 2018 Jun;18(6):627-639. doi: 10.1016/S1473-3099(18)30044-6. Epub 2018 Feb 6.

46.

A controlled human malaria infection model enabling evaluation of transmission-blocking interventions.

Collins KA, Wang CY, Adams M, Mitchell H, Rampton M, Elliott S, Reuling IJ, Bousema T, Sauerwein R, Chalon S, Möhrle JJ, McCarthy JS.

J Clin Invest. 2018 Apr 2;128(4):1551-1562. doi: 10.1172/JCI98012. Epub 2018 Mar 12.

47.

Variation in natural exposure to anopheles mosquitoes and its effects on malaria transmission.

Guelbéogo WM, Gonçalves BP, Grignard L, Bradley J, Serme SS, Hellewell J, Lanke K, Zongo S, Sepúlveda N, Soulama I, Wangrawa DW, Yakob L, Sagnon N, Bousema T, Drakeley C.

Elife. 2018 Jan 23;7. pii: e32625. doi: 10.7554/eLife.32625.

48.

Safety of Single-Dose Primaquine in G6PD-Deficient and G6PD-Normal Males in Mali Without Malaria: An Open-Label, Phase 1, Dose-Adjustment Trial.

Chen I, Diawara H, Mahamar A, Sanogo K, Keita S, Kone D, Diarra K, Djimde M, Keita M, Brown J, Roh ME, Hwang J, Pett H, Murphy M, Niemi M, Greenhouse B, Bousema T, Gosling R, Dicko A.

J Infect Dis. 2018 Mar 28;217(8):1298-1308. doi: 10.1093/infdis/jiy014. Erratum in: J Infect Dis. 2018 Mar 13;217(7):1171.

49.

Safety of single low-dose primaquine in glucose-6-phosphate dehydrogenase deficient falciparum-infected African males: Two open-label, randomized, safety trials.

Bastiaens GJH, Tiono AB, Okebe J, Pett HE, Coulibaly SA, Gonçalves BP, Affara M, Ouédraogo A, Bougouma EC, Sanou GS, Nébié I, Bradley J, Lanke KHW, Niemi M, Sirima SB, d'Alessandro U, Bousema T, Drakeley C.

PLoS One. 2018 Jan 11;13(1):e0190272. doi: 10.1371/journal.pone.0190272. eCollection 2018.

50.

Probabilistic data integration identifies reliable gametocyte-specific proteins and transcripts in malaria parasites.

Meerstein-Kessel L, van der Lee R, Stone W, Lanke K, Baker DA, Alano P, Silvestrini F, Janse CJ, Khan SM, van de Vegte-Bolmer M, Graumans W, Siebelink-Stoter R, Kooij TWA, Marti M, Drakeley C, Campo JJ, van Dam TJP, Sauerwein R, Bousema T, Huynen MA.

Sci Rep. 2018 Jan 11;8(1):410. doi: 10.1038/s41598-017-18840-7.

Supplemental Content

Loading ...
Support Center